Soterix Medical launches Phase 2 RECOVER-NEURO trial in long Covid
The RECOVER-NEURO trial is intended to look at accessible interventions for cognitive dysfunction associated with Covid, such as…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Aug 23
The RECOVER-NEURO trial is intended to look at accessible interventions for cognitive dysfunction associated with Covid, such as…
29 Aug 23
iNNOGING Medical has developed the pioneering cloud-based SaaS solution e Sono for ultrasound simulation that enables users to…
29 Aug 23
Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential…
29 Aug 23
Omnipod 5 is the first CE marked tubeless automated insulin delivery (also known as hybrid closed loop) system…
28 Aug 23
GE HealthCare has designed Vscan Air SL for rapid assessments at the point of care to expedite the…
28 Aug 23
FARAPULSE PFA System is a nonthermal treatment in which electric fields are employed for selectively ablating heart tissue…
28 Aug 23
Ligence Medical AI Solutions’ Ligence Heart will be made available on the Blackford platform to enable clinicians to…
28 Aug 23
SURF intends to help sponsors make an initial feasibility assessment for using real-world data to provide substantial evidence…
28 Aug 23
Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension
25 Aug 23
BAROguard is a next-generation donor lung preservation system, designed to provide optimal temperature range and a clinically recommended…